Healthcare provider profile · identity verified

Philip L Goolsby, MD

Family Practice · GREEN BAY, WI · NPI 1700991718

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pantoprazole Sodium	Pantoprazole Sodium	402	99
Levothyroxine Sodium	Levothyroxine Sodium	326	66
Amlodipine Besylate	Amlodipine Besylate	300	80
Atorvastatin Calcium	Atorvastatin Calcium	265	64
Losartan Potassium	Losartan Potassium	264	61
Lisinopril	Lisinopril	229	56
Rosuvastatin Calcium	Rosuvastatin Calcium	221	56
Pravastatin Sodium	Pravastatin Sodium	218	55
Allopurinol	Allopurinol	212	50
Metformin Hcl Er	Metformin Hcl	200	46
Sertraline Hcl	Sertraline Hcl	179	35
Gabapentin	Gabapentin	169	35
Glimepiride	Glimepiride	169	31
Metoprolol Succinate	Metoprolol Succinate	166	36
Albuterol Sulfate Hfa	Albuterol Sulfate	150	58
Eliquis	Apixaban	134	25
Irbesartan	Irbesartan	130	34
Ezetimibe	Ezetimibe	129	25
Potassium Chloride	Potassium Chloride	129	29
Metoprolol Tartrate	Metoprolol Tartrate	124	25
Lorazepam	Lorazepam	121	21
Atenolol	Atenolol	116	27
Jardiance	Empagliflozin	112	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	112	suppressed
Tizanidine Hcl	Tizanidine Hcl	112	34
Spironolactone	Spironolactone	111	23
Furosemide	Furosemide	108	25
Simvastatin	Simvastatin	106	26
Valsartan	Valsartan	96	18
Telmisartan	Telmisartan	92	22
Metformin Hcl	Metformin Hcl	89	23
Duloxetine Hcl	Duloxetine Hcl	87	18
Trazodone Hcl	Trazodone Hcl	87	17
Buspirone Hcl	Buspirone Hcl	84	19
Arnuity Ellipta	Fluticasone Furoate	83	16
Pregabalin	Pregabalin	76	suppressed
Mirtazapine	Mirtazapine	72	15
Clopidogrel	Clopidogrel Bisulfate	63	11
Omeprazole	Omeprazole	63	21
Tamsulosin Hcl	Tamsulosin Hcl	63	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	suppressed
Diclofenac Sodium	Diclofenac Sodium	59	14
Alendronate Sodium	Alendronate Sodium	58	12
Escitalopram Oxalate	Escitalopram Oxalate	58	16
Januvia	Sitagliptin Phosphate	57	13
Tradjenta	Linagliptin	57	suppressed
Alprazolam	Alprazolam	55	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	53	suppressed
Tramadol Hcl	Tramadol Hcl	53	12
Torsemide	Torsemide	52	suppressed
Warfarin Sodium	Warfarin Sodium	52	15
Hydrochlorothiazide	Hydrochlorothiazide	51	18
Diazepam	Diazepam	50	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	47	suppressed
Celecoxib	Celecoxib	46	11
Meloxicam	Meloxicam	46	15
Fluticasone Propionate	Fluticasone Propionate	45	17
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	44	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	suppressed
Amoxicillin	Amoxicillin	42	24
Symbicort	Budesonide/Formoterol Fumarate	42	suppressed
Carvedilol	Carvedilol	40	12
Cefadroxil	Cefadroxil	39	24
Bisoprolol Fumarate	Bisoprolol Fumarate	36	suppressed
Ventolin Hfa	Albuterol Sulfate	36	14
Clonazepam	Clonazepam	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Xarelto	Rivaroxaban	33	suppressed
Prednisone	Prednisone	32	16
Donepezil Hcl	Donepezil Hcl	31	suppressed
Famotidine	Famotidine	31	11
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Ondansetron Odt	Ondansetron	31	12
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	28	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Linzess	Linaclotide	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Finasteride	Finasteride	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	24	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	22	suppressed
Nitroglycerin	Nitroglycerin	22	16
Ozempic	Semaglutide	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	18
Ketoconazole	Ketoconazole	21	14
Lovastatin	Lovastatin	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Glipizide	Glipizide	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Atrovent Hfa	Ipratropium Bromide	18	suppressed
Baclofen	Baclofen	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	13
Nystatin	Nystatin	18	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	18	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	18	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Febuxostat	Febuxostat	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Nateglinide	Nateglinide	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Topiramate	Topiramate	16	suppressed
Cephalexin	Cephalexin	15	suppressed
Colestipol Hcl	Colestipol Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Pulmicort Flexhaler	Budesonide	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Betamethasone Valerate	Betamethasone Valerate	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Dapsone	Dapsone	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Methylprednisolone	Methylprednisolone	13	11
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Digoxin	Digoxin	11	suppressed
Ethacrynic Acid	Ethacrynic Acid	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Livalo	Pitavastatin Calcium	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Naproxen	Naproxen	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error